Uhr JW - Search Results

1

Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A chain-containing immunotoxins.

Baluna R, Sausville EA, Stone MJ, Stetler-Stevenson MA, Uhr JW, Vitetta ES. Baluna R, et al. Among authors: uhr jw. Clin Cancer Res. 1996 Oct;2(10):1705-12. Clin Cancer Res. 1996. PMID: 9816120 Clinical Trial.

2

The toxicity of chemically deglycosylated ricin A-chain in mice.

Soler-Rodriguez AM, Uhr JW, Richardson J, Vitetta ES. Soler-Rodriguez AM, et al. Among authors: uhr jw. Int J Immunopharmacol. 1992 Feb;14(2):281-91. doi: 10.1016/0192-0561(92)90041-i. Int J Immunopharmacol. 1992. PMID: 1624227

3

Covalent binding of human alpha 2-macroglobulin to deglycosylated ricin A chain and its immunotoxins.

Ghetie MA, Uhr JW, Vitetta ES. Ghetie MA, et al. Among authors: uhr jw. Cancer Res. 1991 Mar 1;51(5):1482-7. Cancer Res. 1991. PMID: 1705175

4

Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites.

Ghetie MA, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES. Ghetie MA, et al. Among authors: uhr jw. Cancer Res. 1991 Nov 1;51(21):5876-80. Cancer Res. 1991. PMID: 1933855

5

An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.

Till M, May RD, Uhr JW, Thorpe PE, Vitetta ES. Till M, et al. Among authors: uhr jw. Cancer Res. 1988 Mar 1;48(5):1119-23. Cancer Res. 1988. PMID: 3257712

6

Pharmacokinetics of tumor-reactive immunotoxins in tumor-bearing mice: effect of antibody valency and deglycosylation of the ricin A chain on clearance and tumor localization.

Fulton RJ, Tucker TF, Vitetta ES, Uhr JW. Fulton RJ, et al. Among authors: uhr jw. Cancer Res. 1988 May 1;48(9):2618-25. Cancer Res. 1988. PMID: 3258546

7

In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.

Fulton RJ, Uhr JW, Vitetta ES. Fulton RJ, et al. Among authors: uhr jw. Cancer Res. 1988 May 1;48(9):2626-31. Cancer Res. 1988. PMID: 3258547

8

Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy.

Vitetta ES, Uhr JW. Vitetta ES, et al. Among authors: uhr jw. Cancer Res. 1994 Oct 15;54(20):5301-9. Cancer Res. 1994. PMID: 7923157 Review. No abstract available.

9

Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome.

Soler-Rodríguez AM, Ghetie MA, Oppenheimer-Marks N, Uhr JW, Vitetta ES. Soler-Rodríguez AM, et al. Among authors: uhr jw. Exp Cell Res. 1993 Jun;206(2):227-34. doi: 10.1006/excr.1993.1142. Exp Cell Res. 1993. PMID: 8388800

10

The toxicity of deglycosylated ricin A chain-containing immunotoxins in patients with non-Hodgkin's lymphoma is exacerbated by prior radiotherapy: a retrospective analysis of patients in five clinical trials.

Schindler J, Sausville E, Messmann R, Uhr JW, Vitetta ES. Schindler J, et al. Among authors: uhr jw. Clin Cancer Res. 2001 Feb;7(2):255-8. Clin Cancer Res. 2001. PMID: 11234876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters